CEOs of autoimmune disease companies
Name | Description | Birthdate | Birthplace | ||
|---|---|---|---|---|---|
Chairman and ceo of Amgen. | January 1, 1963 | ||||
CEO of Vertex Pharmaceuticals. | 1973 | ||||
Dominic Borie, MD, PhD is Chief Executive Officer at Kyverna Therapeutics. Dr. Borie is an accomplished immunologist and digestive tract and liver transplant surgeon with extensive experience in drug development. He joins Kyverna from Horizon Therapeutics where he served as Vice-President and Head, External Research and Development. | |||||
Patrick Soon-Shiong is a professor, surgeon, bioscientist, and founder of NantWorks and other companies. | July 29, 1952 | ||||
CEO of AlloVir | |||||
CEO of Atlas Venture, Magenta Therapeutics & Marqeta, based in United States & New Hampshire | |||||
Businessperson | May 23, 1959 | ||||
Former CEO of Celgene. | |||||
Founder and CEO of Cell Design Labs. | |||||
former CEO of Roche Holding & Roche Pharmaceuticals, based in Newport Beach, California | |||||
founder & CEO of Atlas Venture, based in United States | |||||
CEO of Edesa Biotech. | |||||
Chairman, President, and Chief Executive Officer of TG Therapeutics | |||||
former CEO of eGenesis | |||||
Mr. Spencer, joined Dynavax in 2005 and currently serves as Chief Executive Officer. Previously, Mr. Spencer served as Senior Vice President of Commercial where he was instrumental in leading the launch and commercialization of HEPLISAV-B. | |||||
founder & CEO of Kymera Therapeutics, based in Massachusetts | |||||
CEO of Atlas Venture, Ikena Oncology & Disco Pharmaceuticals | |||||
Founder of Blockchain | |||||
CEO of Atlas Venture & Synlogic, based in Massachusetts | |||||
CEO of Abbvie, Inc. | |||||
Founder of twoXAR | |||||
CEO of Seagen | |||||
Israeli scientist, biologist & geneticist, CEO of Compugen | January 1, 2000 | ||||
CEO of Atlas Venture, Vigil Neurosciences & Draig Therapeutics, based in Massachusetts | |||||
CEO of Intellia Therapeutics |
